Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Infectious Diseases
|
February 21, 2004
Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease
Susana A Laucella, Miriam Postan, Diana Martin, et al.
Journal of Medicinal Chemistry
|
October 29, 2019
Chagas Disease Drug Discovery: Multiparametric Lead Optimization against <i>Trypanosoma cruzi</i> in Acylaminobenzothiazole Series
Charlotte Fleau, Angel Padilla, Juan Miguel-Siles, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 2015
Perturbed T cell IL-7 receptor signaling in chronic Chagas disease
M Cecilia Albareda, Damián Perez-Mazliah, M Ailén Natale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2009
Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy
Susana A Laucella, Damián Pérez Mazliah, Graciela Bertocchi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 11, 2026
Glycosomal Phosphoenolpyruvate Carboxykinase CRISPR/Cas9-Deletion and Its Role in Trypanosoma cruzi Metacyclogenesis and Infectivity in Mammalian Host
Carolina S D Vieira, Wei Wang, Fernando Sanchez-Valdez, et al.
Plos Neglected Tropical Diseases
|
April 30, 2016
Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses
María G Alvarez, Graciela L Bertocchi, Gretchen Cooley, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
Frequency variation and dose modification of benznidazole administration for the treatment of <i>Trypanosoma cruzi</i> infection in mice, dogs and non-human primates
Juan M Bustamante, Brooke E White, Gregory K Wilkerson, et al.
Antimicrobial Agents and Chemotherapy
|
April 11, 2023
Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates
Juan M Bustamante, Brooke E White, Gregory K Wilkerson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 3, 2021
A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses
Huifeng Shen, David Forgacs, Digantkumar Chapla, et al.
NPJ Vaccines
|
December 22, 2017
Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against <i>Trypanosoma cruzi</i> infection
Andrés Sanchez Alberti, Augusto E Bivona, Natacha Cerny, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Infectious Diseases
|
February 21, 2004
Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease
Susana A Laucella, Miriam Postan, Diana Martin, et al.
Journal of Medicinal Chemistry
|
October 29, 2019
Chagas Disease Drug Discovery: Multiparametric Lead Optimization against <i>Trypanosoma cruzi</i> in Acylaminobenzothiazole Series
Charlotte Fleau, Angel Padilla, Juan Miguel-Siles, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 2015
Perturbed T cell IL-7 receptor signaling in chronic Chagas disease
M Cecilia Albareda, Damián Perez-Mazliah, M Ailén Natale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2009
Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy
Susana A Laucella, Damián Pérez Mazliah, Graciela Bertocchi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 11, 2026
Glycosomal Phosphoenolpyruvate Carboxykinase CRISPR/Cas9-Deletion and Its Role in Trypanosoma cruzi Metacyclogenesis and Infectivity in Mammalian Host
Carolina S D Vieira, Wei Wang, Fernando Sanchez-Valdez, et al.
Plos Neglected Tropical Diseases
|
April 30, 2016
Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses
María G Alvarez, Graciela L Bertocchi, Gretchen Cooley, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
Frequency variation and dose modification of benznidazole administration for the treatment of <i>Trypanosoma cruzi</i> infection in mice, dogs and non-human primates
Juan M Bustamante, Brooke E White, Gregory K Wilkerson, et al.
Antimicrobial Agents and Chemotherapy
|
April 11, 2023
Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates
Juan M Bustamante, Brooke E White, Gregory K Wilkerson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 3, 2021
A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses
Huifeng Shen, David Forgacs, Digantkumar Chapla, et al.
NPJ Vaccines
|
December 22, 2017
Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against <i>Trypanosoma cruzi</i> infection
Andrés Sanchez Alberti, Augusto E Bivona, Natacha Cerny, et al.
Page
of 10